| Literature DB >> 30635649 |
Tessa Dhaeze1, Laurence Tremblay1, Catherine Lachance1, Evelyn Peelen1, Stephanie Zandee1, Camille Grasmuck1, Lyne Bourbonnière1, Sandra Larouche1, Xavier Ayrignac1,2, Rose-Marie Rébillard1, Josée Poirier2, Boaz Lahav2, Pierre Duquette1,2, Marc Girard1,2, Robert Moumdjian3, Alain Bouthillier3, Catherine Larochelle1,2, Alexandre Prat4,5.
Abstract
CD70 is the unique ligand of CD27 and is expressed on immune cells only upon activation. Therefore, engagement of the costimulatory CD27/CD70 pathway is solely dependent on upregulation of CD70. However, the T cell-intrinsic effect and function of human CD70 remain underexplored. Herein, we describe that CD70 expression distinguishes proinflammatory CD4+ T lymphocytes that display an increased potential to migrate into the central nervous system (CNS). Upregulation of CD70 on CD4+ T lymphocytes is induced by TGF-β1 and TGF-β3, which promote a pathogenic phenotype. In addition, CD70 is associated with a TH1 and TH17 profile of lymphocytes and is important for T-bet and IFN-γ expression by both T helper subtypes. Moreover, adoptive transfer of CD70-/-CD4+ T lymphocytes induced less severe experimental autoimmune encephalomyelitis (EAE) disease than transfer of WT CD4+ T lymphocytes. CD70+CD4+ T lymphocytes are found in the CNS during acute autoimmune inflammation in humans and mice, highlighting CD70 as both an immune marker and an important costimulator of highly pathogenic proinflammatory TH1/TH17 lymphocytes infiltrating the CNS.Entities:
Keywords: CD27/CD70 pathway; CD70+CD4+ T lymphocytes; TCR1640 transgene mouse model; TGF-β1; TGF-β3; blood-brain barrier; endothelial cells; experimental autoimmune encephalitis; multiple sclerosis; soluble CD70
Mesh:
Substances:
Year: 2019 PMID: 30635649 PMCID: PMC6804668 DOI: 10.1038/s41423-018-0198-5
Source DB: PubMed Journal: Cell Mol Immunol ISSN: 1672-7681 Impact factor: 11.530